AnteoTech (ASX:ADO) Beneish M-Score : 0.00 (As of Dec. 12, 2024)

View and export this data going back to 2000. Start your Free Trial

What is AnteoTech Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for AnteoTech's Beneish M-Score or its related term are showing as below:

During the past 13 years, the highest Beneish M-Score of AnteoTech was 42.90. The lowest was -8.87. And the median was -7.60.

AnteoTech Beneish M-Score Historical Data

The historical data trend for AnteoTech's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnteoTech Beneish M-Score Chart

AnteoTech Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Beneish M-Score

Get a 7-Day Free Trial

-8.87

AnteoTech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Beneish M-Score	Get a 7-Day Free Trial															-	-	-8.87	-	-

Competitive Comparison of AnteoTech's Beneish M-Score

For the Biotechnology subindustry, AnteoTech's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AnteoTech's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AnteoTech's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where AnteoTech's Beneish M-Score falls into.

AnteoTech Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of AnteoTech for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 *

0.528 *

0.404 *

0.892 *

0.115 *

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 *

4.679 *

0.327 *

This Year (Jun24) TTM:

Last Year (Jun23) TTM:

Total Receivables was A$0.21 Mil.
Revenue was A$0.46 Mil.
Gross Profit was A$0.46 Mil.
Total Current Assets was A$5.45 Mil.
Total Assets was A$9.38 Mil.
Property, Plant and Equipment(Net PPE) was A$3.90 Mil.
Depreciation, Depletion and Amortization(DDA) was A$1.04 Mil.
Selling, General, & Admin. Expense(SGA) was A$5.92 Mil.
Total Current Liabilities was A$1.79 Mil.
Long-Term Debt & Capital Lease Obligation was A$1.69 Mil.
Net Income was A$-8.88 Mil.
Gross Profit was A$3.83 Mil.
Cash Flow from Operations was A$-6.52 Mil.

Total Receivables was A$0.20 Mil.
Revenue was A$0.37 Mil.
Gross Profit was A$0.37 Mil.
Total Current Assets was A$3.14 Mil.
Total Assets was A$5.36 Mil.
Property, Plant and Equipment(Net PPE) was A$2.22 Mil.
Depreciation, Depletion and Amortization(DDA) was A$1.00 Mil.
Selling, General, & Admin. Expense(SGA) was A$6.88 Mil.
Total Current Liabilities was A$1.80 Mil.
Long-Term Debt & Capital Lease Obligation was A$0.66 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(0.207 / 0.46)	/	(0.198 / 0.366)
	=	0.45	/	0.540984
	=

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(0.366 / 0.366)	/	(0.46 / 0.46)
	=	1	/	1
	=

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (5.454 + 3.897) / 9.381)	/	(1 - (3.142 + 2.22) / 5.362)
	=	0.003198	/	0
	=

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	0.46	/	0.366
	=

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.999 / (0.999 + 2.22))	/	(1.04 / (1.04 + 3.897))
	=	0.310345	/	0.210654
	=

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(5.917 / 0.46)	/	(6.876 / 0.366)
	=	12.863043	/	18.786885
	=

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((1.688 + 1.793) / 9.381)	/	((0.659 + 1.804) / 5.362)
	=	0.371069	/	0.459344
	=

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(-8.881 - 3.831	-	-6.521)	/	9.381
	=	-0.659951

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

AnteoTech Beneish M-Score Related Terms

Thank you for viewing the detailed overview of AnteoTech's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

AnteoTech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnteoTech Ltd (ASX:ADO) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

4/26 Brandl Street, Eight Mile Plains, Brisbane, QLD, AUS, 4113

Website

https://www.anteotech.com

AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.

AnteoTech Headlines

No Headlines